Sigilon Therapeutics, Inc. Annual Interest Expense in USD from 2020 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Sigilon Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from 2020 to 2022.
  • Sigilon Therapeutics, Inc. Interest Expense for the quarter ending June 30, 2023 was $310K, a 42.9% decline year-over-year.
  • Sigilon Therapeutics, Inc. Interest Expense for the twelve months ending June 30, 2023 was $2.18M, a 6.72% increase year-over-year.
  • Sigilon Therapeutics, Inc. annual Interest Expense for 2022 was $2.29M, a 15.2% increase from 2021.
  • Sigilon Therapeutics, Inc. annual Interest Expense for 2021 was $1.99M, a 65.4% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $2.29M +$302K +15.2% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-14
2021 $1.99M +$786K +65.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-14
2020 $1.2M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.